Madrigal Pharmaceuticals Inc (MDGL)
194.36
-10.29
(-5.03%)
USD |
NASDAQ |
Apr 25, 16:00
194.01
-0.35
(-0.18%)
After-Hours: 20:00
Madrigal Pharmaceuticals Market Cap: 3.867B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 4.072B |
| April 23, 2024 | 4.345B |
| April 22, 2024 | 4.248B |
| April 19, 2024 | 4.219B |
| April 18, 2024 | 4.422B |
| April 17, 2024 | 4.543B |
| April 16, 2024 | 4.636B |
| April 15, 2024 | 4.604B |
| April 12, 2024 | 4.708B |
| April 11, 2024 | 4.880B |
| April 10, 2024 | 4.868B |
| April 09, 2024 | 4.961B |
| April 08, 2024 | 4.947B |
| April 05, 2024 | 4.836B |
| April 04, 2024 | 4.804B |
| April 03, 2024 | 4.879B |
| April 02, 2024 | 4.865B |
| April 01, 2024 | 5.089B |
| March 28, 2024 | 5.313B |
| March 27, 2024 | 5.150B |
| March 26, 2024 | 4.927B |
| March 25, 2024 | 4.927B |
| March 22, 2024 | 4.939B |
| March 21, 2024 | 5.079B |
| March 20, 2024 | 5.153B |
| Date | Value |
|---|---|
| March 19, 2024 | 5.286B |
| March 18, 2024 | 5.636B |
| March 15, 2024 | 5.380B |
| March 14, 2024 | 4.846B |
| March 13, 2024 | 5.432B |
| March 12, 2024 | 5.226B |
| March 11, 2024 | 5.176B |
| March 08, 2024 | 5.080B |
| March 07, 2024 | 4.995B |
| March 06, 2024 | 5.121B |
| March 05, 2024 | 4.944B |
| March 04, 2024 | 4.906B |
| March 01, 2024 | 5.007B |
| February 29, 2024 | 4.700B |
| February 28, 2024 | 5.059B |
| February 27, 2024 | 4.771B |
| February 26, 2024 | 4.628B |
| February 23, 2024 | 4.707B |
| February 22, 2024 | 4.945B |
| February 21, 2024 | 4.536B |
| February 20, 2024 | 4.566B |
| February 16, 2024 | 4.634B |
| February 15, 2024 | 4.417B |
| February 14, 2024 | 4.332B |
| February 13, 2024 | 4.070B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
927.76M
Minimum
Apr 03 2020
5.704B
Maximum
Apr 28 2023
2.266B
Average
1.645B
Median
May 15 2019
Market Cap Benchmarks
| Eli Lilly and Co | 689.30B |
| Viking Therapeutics Inc | 6.924B |
| Akero Therapeutics Inc | 1.304B |
| 89bio Inc | 786.56M |
| Geron Corp | 1.949B |
Market Cap Related Metrics
| PS Ratio | 551.31 |
| Price to Book Value | 9.541 |
| Price | 194.36 |
| Earnings Yield | -10.28% |